Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Efficacy of Continuous Apomorphine Infusion on Cognitive and Neuropsychological Functions in Parkinson's Disease

Trial Phase 3 Completed May 23, 2023

Transcranial Direct Current Stimulation and Dual Tasks

Trial N/A Unknown May 22, 2023

A Study Into the Underlying Biochemical Pathways Involved in Parkinson's Disease, Such as Mitochondrial (Cellular "Powerhouse") Dysfunction

Trial N/A Completed May 22, 2023

Effect of Safinamide on Parkinson's Disease Related Chronic Pain

Trial Phase 4 Completed May 21, 2023

Pilot Study to Determine if Working Memory Training Aids Cognitive Functioning in Patients With Parkinson's Disease

Trial N/A Unknown May 18, 2023

Cryotherapy Versus Radiofrequency Ablation for Treatment of Para-hisian Accessory Pathways

Trial N/A Completed May 18, 2023

Emotion Study/Substudy: Flexible Brain Study

Trial N/A Completed May 16, 2023

Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PD

Trial N/A Unknown May 16, 2023

A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD

Trial Phase 1 Completed May 15, 2023

The Natural History of Parkinson's Disease-associated Spinal Disorders

Trial N/A Withdrawn May 11, 2023

e-Mobile Tablet for People With Chronic Conditions

Trial N/A Completed May 11, 2023

Comparison of Effects of TT With and Without Visual and Auditory Cues for Freezing & Gait Patients With PD

Trial N/A Unknown May 10, 2023

Effect of WB-EMS on Parkinson's Disease

Trial N/A Unknown May 10, 2023

Socio-Clinical Factors Associated With Self-Management in Parkinson's Disease

Trial N/A Completed May 10, 2023

Digitised Home Based Care for Parkinson's Disease

Trial N/A Unknown May 10, 2023

GRoningen Early-PD Ambroxol Treatment

Trial Phase 2 Unknown May 9, 2023

Quantitative Assessment of Training Effects Using EKSOGT Exoskeleton in Quantitative Assessment of Training Effects Using EKSOGT Exoskeleton in Parkinson Disease Patients

Trial N/A Unknown May 9, 2023

[18F]MC225-PET in Neurodegenerative Disease

Trial Phase 1 Unknown May 9, 2023

Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate

Trial Phase 4 Completed May 9, 2023

Neuroprotective Effects of iTBS in PD

Trial N/A Unknown May 8, 2023